468 related articles for article (PubMed ID: 15530425)
1. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression.
Soehnlein O; Schmeisser A; Cicha I; Reiss C; Ulbrich H; Lindbom L; Daniel WG; Garlichs CD
J Vasc Res; 2005; 42(5):399-407. PubMed ID: 16088213
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Ruiz-Ortega M; Bustos C; Hernández-Presa MA; Lorenzo O; Plaza JJ; Egido J
J Immunol; 1998 Jul; 161(1):430-9. PubMed ID: 9647253
[TBL] [Abstract][Full Text] [Related]
4. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
6. [Effect of angiotensin II on tissue factor expression in human peripheral blood monocytes and its mechanisms].
He MX; He XF; Xie QZ; Chen FP; He SL
Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):470-3. PubMed ID: 14575590
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.
Guo RW; Yang LX; Wang H; Liu B; Wang L
Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
He M; He X; Xie Q; Chen F; He S
Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
[TBL] [Abstract][Full Text] [Related]
11. [Effect of angiotensin II type 1 receptor and angiotensin-converting enzyme gene silencing on nuclear factor-kappaB activity in hepatic stellate cells].
Li X; Zhang YJ; Meng Y; Zhou GS; Zhang ZS
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):402-4. PubMed ID: 19304510
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
14. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
15. Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.
Watanabe K; Taniguchi M; Miyoshi M; Shimizu H; Imoto T; Sato K; Watanabe T
Peptides; 2006 Jun; 27(6):1538-46. PubMed ID: 16356591
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB.
Skurk T; van Harmelen V; Hauner H
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1199-203. PubMed ID: 15130920
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation.
Takeuchi Y; Yamauchi K; Nakamura J; Shigematsu S; Hashizume K
J Endocrinol; 2006 Nov; 191(2):361-7. PubMed ID: 17088405
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.
Kranzhöfer R; Browatzki M; Schmidt J; Kübler W
Biochem Biophys Res Commun; 1999 Apr; 257(3):826-8. PubMed ID: 10208867
[TBL] [Abstract][Full Text] [Related]
20. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]